ARTICLE | Management Tracks
Plus: Baptista joins SmartCella and updates from LifeArc and Gain
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
April 19, 2024 9:50 PM UTC
Cell therapy company Sana Biotechnology Inc. (NASDAQ:SANA) announced in an SEC filing the departure of EVP and President, R&D Doug Williams. The company did not disclose a successor to Williams, who joined Sana last April. Williams was co-founder and CEO of exosome company Codiak Biosciences Inc. (NASDAQ:CDAK) before joining Sana. Before Codiak, he served as EVP of R&D at Biogen Inc. (NASDAQ:BIIB).
SmartCella Holding AB, which is developing stem cell and RNA-based therapies, hired Ricardo Baptista as CTO. Baptista was CTO at Alder Therapeutics AB. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652170/doug-williams-leaving-sana